NO20061357L - Chelerytrin, analoger derav og deres anvendelse i behandling av bipolare, forstyrrelser og andre koginitive forstyrrelser - Google Patents

Chelerytrin, analoger derav og deres anvendelse i behandling av bipolare, forstyrrelser og andre koginitive forstyrrelser

Info

Publication number
NO20061357L
NO20061357L NO20061357A NO20061357A NO20061357L NO 20061357 L NO20061357 L NO 20061357L NO 20061357 A NO20061357 A NO 20061357A NO 20061357 A NO20061357 A NO 20061357A NO 20061357 L NO20061357 L NO 20061357L
Authority
NO
Norway
Prior art keywords
alkyl
chelerytrin
disorders
pharmaceutically acceptable
analogs
Prior art date
Application number
NO20061357A
Other languages
English (en)
Norwegian (no)
Inventor
Amy F T Arnsten
Shari G Birnbaum
Original Assignee
Univ Yale
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Yale filed Critical Univ Yale
Publication of NO20061357L publication Critical patent/NO20061357L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4741—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having oxygen as a ring hetero atom, e.g. tubocuraran derivatives, noscapine, bicuculline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
NO20061357A 2003-09-26 2006-03-24 Chelerytrin, analoger derav og deres anvendelse i behandling av bipolare, forstyrrelser og andre koginitive forstyrrelser NO20061357L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/672,626 US20050070565A1 (en) 2003-09-26 2003-09-26 Chelerythrine, analogs thereof and their use in the treatment of bipolar disorder and other cognitive disorders
PCT/US2004/031567 WO2005030143A2 (en) 2003-09-26 2004-09-27 Chelerythrine, analogs thereof and their use in the treatment of bipolar disorder and other cognitive disorders

Publications (1)

Publication Number Publication Date
NO20061357L true NO20061357L (no) 2006-06-16

Family

ID=34376422

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20061357A NO20061357L (no) 2003-09-26 2006-03-24 Chelerytrin, analoger derav og deres anvendelse i behandling av bipolare, forstyrrelser og andre koginitive forstyrrelser

Country Status (11)

Country Link
US (2) US20050070565A1 (ja)
EP (1) EP1662875A4 (ja)
JP (1) JP2007506784A (ja)
CN (1) CN1859846A (ja)
AU (1) AU2004275852A1 (ja)
BR (1) BRPI0414816A (ja)
CA (1) CA2540151A1 (ja)
IL (1) IL174303A0 (ja)
MX (1) MXPA06003423A (ja)
NO (1) NO20061357L (ja)
WO (1) WO2005030143A2 (ja)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7928070B2 (en) * 2000-04-20 2011-04-19 The Research Foundation Of State University Of Ny Memory enhancing protein
US20080145351A1 (en) * 2000-04-20 2008-06-19 The Research Foundation Of State University Of New York Memory influencing protein
WO2007089774A2 (en) * 2006-01-31 2007-08-09 Yale University Compositions and methods for treating cognitive disorders
US8362028B2 (en) * 2006-07-31 2013-01-29 Yale University Pseudobase benzo[c]phenanthridines with improved efficacy, stability and safety
WO2008048194A1 (en) * 2006-10-20 2008-04-24 Yesilogluj Aysegul Yildiz Use of the protein kinase c inhibitor tamoxifen for the treatment of bipolar disorder
CN101209043B (zh) * 2006-12-27 2011-08-10 长沙世唯科技有限公司 血根碱或白屈菜红碱在血吸虫病防治上的应用
US20080318992A1 (en) * 2007-03-22 2008-12-25 Yale University Method of using a pkc inhibitor to reverse prefrontal cortical declines
WO2011022292A2 (en) * 2009-08-19 2011-02-24 Lunera Research, Inc. Method of treating bipolar disorder or depression using an antiestrogen
US20170189391A1 (en) * 2015-12-31 2017-07-06 Macau University of Science ang Technology Protein kinase C inhibitor for treating triple-negative breast cancer

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683133A (en) * 1985-08-20 1987-07-28 Vipont Laboratories, Inc. Method for treating periodontal disease
US5747502A (en) * 1989-12-13 1998-05-05 Nippon Kayaku Kabushiki Kaisha Process for preparing benzo c!phenanthridinium derivatives, novel compounds prepared by said process, and antitumor agents
JP2784104B2 (ja) * 1991-08-06 1998-08-06 三菱電機株式会社 タイミングシミュレーションシステム
US5922571A (en) * 1997-03-06 1999-07-13 Incyte Pharmaceuticals, Inc. Polynucleotides encoding a protein kinase C homolog
US6717030B2 (en) * 1998-07-06 2004-04-06 The Regents Of The University Of California Protein kinase C epsilon as modulator of anxiety, alcohol consumption and self-administration of drugs of abuse
AUPQ801700A0 (en) * 2000-06-07 2000-06-29 Peplin Research Pty Ltd Enzyme and viral activation
US6664266B2 (en) * 2002-03-14 2003-12-16 Children's Medical Center Corporation Axon regeneration with PKC inhibitiors

Also Published As

Publication number Publication date
IL174303A0 (en) 2006-08-01
JP2007506784A (ja) 2007-03-22
AU2004275852A1 (en) 2005-04-07
CA2540151A1 (en) 2005-04-07
EP1662875A4 (en) 2009-04-15
CN1859846A (zh) 2006-11-08
WO2005030143A2 (en) 2005-04-07
MXPA06003423A (es) 2006-06-27
EP1662875A2 (en) 2006-06-07
US20100222376A1 (en) 2010-09-02
WO2005030143A3 (en) 2005-09-15
BRPI0414816A (pt) 2006-11-14
US20050070565A1 (en) 2005-03-31

Similar Documents

Publication Publication Date Title
NO20061357L (no) Chelerytrin, analoger derav og deres anvendelse i behandling av bipolare, forstyrrelser og andre koginitive forstyrrelser
BRPI0308696B8 (pt) composto derivado de quinolina, seu processo de preparação, sua composição farmacêutica e seus usos
AR041566A1 (es) Derivados de indol utiles para el tratamiento de enfermedades
NO960713D0 (no) Substituerte azaindolylidenforbindelser og fremgangsmåte for deres fremstilling
KR100878416B1 (ko) 피페라진 화합물
AR040500A1 (es) Inhibidores de cinasas
NO963066D0 (no) Substituerte 3-aryliden-7-azaoksindolforbindelser og fremgangsmåte for deres fremstilling
AR033525A1 (es) Arilmetilaminas sustituidas, composiciones farmaceuticas, uso de las mismas para la manufactura de un medicamento
AP2001002307A0 (en) B3 adrenergic receptor agonists and uses thereof.
YU8703A (sh) Derivati 4-fenil-piridina kao antagonisti receptora neurokinina-1
AR035479A1 (es) Derivados de eteres biarilicos y sus sales, composiciones farmaceuticas que los comprenden y procedimientos para el tratamiento de trastornos o afecciones
GB9524157D0 (en) Therapeutic agents
AR057810A1 (es) Inhibidores ns5b de vhc de indolobenzazepina fusionados a ciclopropilo y composicion farmaceutica
HRP20020175B1 (en) N-heterocyclikc derivatives as nos inhibitors
AR070950A1 (es) Compuestos derivados de amina, composiciones farmaceuticas de ellos, compuestos inhibidores de produccion de 11-cis-retinol y metodos para tratar enfermedades y trastornos oftalmicos
BRPI0519287A2 (pt) derivados de amida
HUP0402225A2 (hu) Makrolid-vegyületek, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
HUP0101281A2 (hu) Glicin transzport inhibitor hatású difenil-piperidin-butánamid-származékok, eljárás előállításukra, alkalmazásuk gyógyszerkészítmények előállítására és a vegyületeket tartalmazó gyógyszerkészítmények
RS49684B (sr) Upotreba derivata 7-(2-oksa-5,8- diazabiciklo[4.3.0]non-8-il)-hinolon- karbonske kiseline i nafthiridonkarbonske kiseline za pripremanje leka za terapiju helikobakter-pilori infekcija i sa time povezanim gastroduodenalnim oboljenjima
PE20090620A1 (es) Derivados de 1,2,4,5-tetrahidro-3h-benzazepinas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen
NO20063597L (no) Acetylinske piperazinforbindelser og deres anvendelse som metabotrofiske glutamatreseptorantagonister
EA200300424A1 (ru) Соли изотиазол-4-карбоксамида и их применение в качестве антигиперпролиферативных агентов
TW200740760A (en) Malonamide derivatives
NO20074622L (no) Metabolitter for NK-1 antagonister for brekninger
AR042480A1 (es) Derivados de la quinazolina para el trtamiento del crecimiento celular anormal

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application